Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
10%
Ph not_applicable
4
40%
Ph phase_2
1
10%
Ph phase_4
3
30%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 4Post-market surveillance
3(33.3%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(5)
Other(4)

Detailed Status

Completed5
unknown4
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 43 (33.3%)
N/A4 (44.4%)

Trials by Status

not_yet_recruiting110%
completed550%
unknown440%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10